Answers are grounded in this paper and cite their sources.
Drug-induced liver injury is still poorly understood and more objective assessments are warranted. Reporting of adverse events should be strongly advocated to facilitate future analyses and the understanding of risk-benefit profiles of CAM.
No takes yet. Share an insight, caveat, or question.
Teo et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: